RPL7 and brucellosis: In this study, we first developed recombinant influenza A viruses of the subtypes Н5N1 and H1N1 expressing Brucella ribosomal protein L7/L12 or Omp16, and then demonstrated that these vaccines could be used as new candidates for a brucellosis vaccine.